
Zydus Lifesciences Ltd
Market Capital : 88,548.59 Cr.
P/E Ratio : 18.94
P/B Ratio : 5.1
Book Value Per Share : 219.7
EPS : 38.14
Dividend Yield : 0.34 %
Revenue Growth : 16.96 %
Profit Growth : 96.88 %
Market Capital : 88,548.59 Cr.
P/E Ratio : 18.94
P/B Ratio : 5.1
Book Value Per Share : 219.7
EPS : 38.14
Dividend Yield : 0.34 %
Revenue Growth : 16.96 %
Profit Growth : 96.88 %
Strengths
Weaknesses
COMPANY NAME | CURRENT PRICE | PE RATIO | REVENUE GROWTH | PROFIT GROWTH |
---|---|---|---|---|
₹1,819 |
38.14 |
10.46% |
13.01% |
|
₹6,114 |
78.52 |
25.01% |
-12.25% |
|
₹1,512 |
24.47 |
7.10% |
47.10% |
|
₹1,159 |
18 |
15.81% |
23.75% |
|
₹2,405 |
48.61 |
23.90% |
49.23% |
|
₹3,249 |
59.05 |
2.82% |
33.02% |
|
₹2,091 |
33.28 |
10.97% |
345.15% |
As per the National Stock Exchange, Zydus Lifesciences Ltd’s ticker symbol is "ZYDUSLIFE".
The Zydus Lifesciences Ltd’s market capitalization is ₹ 88548.59 Cr.
As of now, the Zydus Lifesciences Ltd’s market capitalization is ₹88548.59 Cr, which puts it into the category of large-cap companies. This can indicate, the Zydus Lifesciences Ltd is stable and Established in the industry. If you finding a company to invest in that is less risky, has consistent growth and a stable dividend yield then this can be good to go.